KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung CancerBusiness Wire • Saturday
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell LymphomaBusiness Wire • Thursday
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • Thursday
2024 is being called ‘the year of the dividend.' These 5 stocks keep on giving.Market Watch • Wednesday
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial CarcinomaBusiness Wire • Wednesday
Menten AI Announces Completion of Research Collaboration with Bristol Myers SquibbBusiness Wire • Tuesday
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research PlatformsBusiness Wire • 05/23/24
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&ACNBC • 05/23/24
Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying OpportunitySeeking Alpha • 05/23/24
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual MeetingBusiness Wire • 05/23/24
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income CountriesBusiness Wire • 05/22/24
NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers SquibbPRNewsWire • 05/22/24
Top Wall Street Strategist Sees 500 Point S&P 500 Drop – Buy 6 Passive Income Dividend Stocks Now24/7 Wall Street • 05/21/24
Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible CampaignBusiness Wire • 05/21/24